rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2004-11-24
|
pubmed:abstractText |
To perform a quantitative analysis of DNA ploidy, S-phase fraction % (SPF%), p53 and multidrug resistance (MDR) gene expression as independent prognostic parameters and to compare these parameters with stage of the disease in multiple myeloma (MM) patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0884-6812
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
271-7
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:15560533-Adolescent,
pubmed-meshheading:15560533-Adult,
pubmed-meshheading:15560533-Aged,
pubmed-meshheading:15560533-Aged, 80 and over,
pubmed-meshheading:15560533-Antineoplastic Agents,
pubmed-meshheading:15560533-Biological Markers,
pubmed-meshheading:15560533-DNA,
pubmed-meshheading:15560533-Female,
pubmed-meshheading:15560533-Flow Cytometry,
pubmed-meshheading:15560533-Humans,
pubmed-meshheading:15560533-Male,
pubmed-meshheading:15560533-Middle Aged,
pubmed-meshheading:15560533-Multiple Myeloma,
pubmed-meshheading:15560533-P-Glycoproteins,
pubmed-meshheading:15560533-Ploidies,
pubmed-meshheading:15560533-Prognosis,
pubmed-meshheading:15560533-S Phase,
pubmed-meshheading:15560533-Tumor Suppressor Protein p53
|
pubmed:year |
2004
|
pubmed:articleTitle |
Flow cytometric analysis of DNA indices, expression of p53 and multidrug resistance genes in multiple myeloma patients.
|
pubmed:affiliation |
Department of Haematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
|
pubmed:publicationType |
Journal Article
|